1. Chai, Annie Wai Yeeng, Cheung, Arthur Kwok Leung, Dai, Wei, Law, Simon, Lung, Maria Li. . Metastasis-suppressing NID2, an epigenetically-silenced gene, in the pathogenesis of nasopharyngeal carcinoma and esophageal squamous cell carcinoma. In Oncotarget, 7, 78859-78871. doi:10.18632/oncotarget.12889. https://pubmed.ncbi.nlm.nih.gov/27793011/
2. Mao, Chenfeng, Ma, Zihan, Jia, Yiting, Fu, Yi, Kong, Wei. 2021. Nidogen-2 Maintains the Contractile Phenotype of Vascular Smooth Muscle Cells and Prevents Neointima Formation via Bridging Jagged1-Notch3 Signaling. In Circulation, 144, 1244-1261. doi:10.1161/CIRCULATIONAHA.120.053361. https://pubmed.ncbi.nlm.nih.gov/34315224/
3. Wang, Jianfeng, Zhao, Yan, Xu, Hongyan, Zou, Qingxu, Lin, Fengwu. 2019. Silencing NID2 by DNA Hypermethylation Promotes Lung Cancer. In Pathology oncology research : POR, 26, 801-811. doi:10.1007/s12253-019-00609-0. https://pubmed.ncbi.nlm.nih.gov/30826972/
4. Sha, Yan, Mao, An-Qi, Liu, Yuan-Jie, Wu, Mu-Yao, Shen, Hui. 2023. Nidogen-2 (NID2) is a Key Factor in Collagen Causing Poor Response to Immunotherapy in Melanoma. In Pharmacogenomics and personalized medicine, 16, 153-172. doi:10.2147/PGPM.S399886. https://pubmed.ncbi.nlm.nih.gov/36908806/
5. Yu, Zhi-Hao, Wang, Yue-Mei, Jiang, Yu-Zhang, Wan, Yi-Yuan, Wang, Xiao-Wei. 2019. NID2 can serve as a potential prognosis prediction biomarker and promotes the invasion and migration of gastric cancer. In Pathology, research and practice, 215, 152553. doi:10.1016/j.prp.2019.152553. https://pubmed.ncbi.nlm.nih.gov/31362888/
智鼠故事 
